Uniting Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$513K Sell
3,965
-91
-2% -$10.7K 0.1% 115
2026
Q1
$491K Sell
4,056
-201
-5% -$23.2K 0.1% 113
2025
Q4
$452K Buy
4,257
+297
+8% +$27.9K 0.14% 86
2025
Q3
$336K Buy
+3,960
New +$326K 0.08% 130
2025
Q1
– Sell
-2,481
Closed -$247K – 122
2024
Q4
$247K Buy
+2,481
New +$256K 0.12% 81

Other funds holding MRK

Uniting Wealth Partners's MRK Position: Q2 2026 in Review

Uniting Wealth Partners reduced its Merck (MRK) stake by 2.2% in Q2 2026, selling an estimated $10.7K and leaving 3,965 shares worth $513K. The position accounts for 0.1% of the portfolio, ranked #115.

Uniting Wealth Partners first reported a position in MRK in Q4 2024 and has held it in 5 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Uniting Wealth Partners held 3,965 shares of Merck worth $513K as of Q2 2026.
  • Uniting Wealth Partners sold 91 Merck shares in Q2 2026, an estimated $10.7K.
  • Merck made up 0.1% of Uniting Wealth Partners's portfolio in Q2 2026, its #115 holding.
  • Uniting Wealth Partners first reported a position in Merck in Q4 2024 and has held it in 5 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Uniting Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.